Fig. 2From: Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormalitya–c Chest CT showed interstitial changes in the lower lobe of the right lung after oral administration of almonertinib for 3 monthsBack to article page